PMID: 9647602Jul 1, 1998Paper

Pharmacology of leukotriene receptor antagonists

American Journal of Respiratory and Critical Care Medicine
D Aharony

Abstract

Preclinical pharmacological studies have demonstrated that cysLT, receptor antagonists, such as zafirlukast, montelukast, and pobilukast, are potent and selective antagonists of cysteinyl leukotriene (cysLT) activity. In vitro, these agents compete with [3H]LTD4 for binding to cysLT, receptors present on guinea pig and human lung cell membranes. Both zafirlukast and montelukast have affinities that are approximately two times greater than that of the natural ligand, LTD4. These agents block LTD4- and LTE4-induced contractions of isolated guinea pig trachea, but do not antagonize LTC4-induced contractions, which are putatively mediated by a different LT receptor, cysLT2. The cysLT2 receptor, however, has not yet been found in human airway smooth muscle. In animal models, these drugs inhibit LTD4-, LTE4-, and antigen-induced bronchoconstriction, reduce inflammatory markers in models of pulmonary inflammation, and inhibit antigen-induced late-phase bronchoconstriction. This preclinical profile suggests that cysLT, receptor antagonists may be useful in treating inflammatory conditions of the respiratory system, such as asthma and allergic rhinitis.

Citations

Mar 23, 2011·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Ahmed M MohamadinFahad A Al-Abbasi
Dec 14, 2004·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Göksel SenerGül Ayanoğlu-Dülger
Nov 16, 2004·European Journal of Pharmacology·Flora FerrariFrancesco Makovec
Sep 16, 2005·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Göksel SenerBerrak C Yeğen
Oct 6, 2005·European Journal of Pharmacology·Jacquelina FernandezMaria G Campos
Jul 4, 2015·Nature Reviews. Immunology·Edward A Dennis, Paul C Norris
May 26, 2015·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Alper OtunctemurNurver Ozbay
Jul 2, 2008·Bioorganic & Medicinal Chemistry Letters·Seock-Kyu KhimWilliam J Guilford
Jul 1, 2008·Bioorganic & Medicinal Chemistry Letters·Bin YeWilliam J Guilford
Dec 12, 2001·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·B J Lipworth
Sep 14, 2017·Journal of Biochemical and Molecular Toxicology·Amany M GadDalaal M Abdallah
Mar 19, 2004·European Journal of Gastroenterology & Hepatology·Nevin OrucYucel Batur

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

American Thoracic Association Journals

Discover the latest respiratory research published by the journals from the American Thoracic Society.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.